These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1691414)

  • 1. Patient compliance and angiotensin converting enzyme inhibitors in hypertension.
    Juncos LI
    J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S22-5. PubMed ID: 1691414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
    Brunner HR; Bidiville J; Waeber G; Porchet M; Nussberger J; Waeber B
    Nephron; 1987; 47 Suppl 1():87-9. PubMed ID: 2827044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitor versus beta-blocker in the treatment of essential hypertension.
    Edmonds D; Knorr M; Greminger P; Walger P; Frielingsdorf J; Vetter H; Vetter W
    Nephron; 1987; 47 Suppl 1():90-3. PubMed ID: 2827045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
    Napoli C; Bruzzese G; Ignarro LJ; Crimi E; de Nigris F; Williams-Ignarro S; Libardi S; Sommese L; Fiorito C; Mancini FP; Cacciatore F; Liguori A
    Am Heart J; 2008 Dec; 156(6):1154.e1-8. PubMed ID: 19033012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of coronary flow reserve after long-term therapy with enalapril.
    Motz W; Strauer BE
    Hypertension; 1996 May; 27(5):1031-8. PubMed ID: 8621193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
    Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
    Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
    Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.
    Danilov SM; Tovsky SI; Schwartz DE; Dull RO
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):374-386. PubMed ID: 28587581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of monotherapy with enalapril and atenolol in mild to moderate hypertension. The Canadian Enalapril Study Group.
    CMAJ; 1987 Nov; 137(9):803-8. PubMed ID: 2894890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
    Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M
    Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the efficacy of captopril and enalapril in single doses in the treatment of arterial hypertension. Evaluation by means of non-invasive ambulatory monitoring].
    Valori C; Gambini G; Canini F; Marinelli M; Rossi S; Pinchi G
    Clin Ter; 1989 Jul; 130(1):37-44. PubMed ID: 2551565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.
    Nawarskas JJ; Townsend RR; Cirigliano MD; Spinler SA
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):784-9. PubMed ID: 10480471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of enalapril and atenolol in mild to moderate hypertension.
    Herrick AL; Waller PC; Berkin KE; Pringle SD; Callender JS; Robertson MP; Findlay JG; Murray GD; Reid JL; Lorimer AR
    Am J Med; 1989 Apr; 86(4):421-6. PubMed ID: 2539017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
    Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
    J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
    Mallion JM; Dutrey-Dupagne C; Vaur L; Genes N; Renault M; Elkik F; Baguet P; Boutelant S
    J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.